KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $25.9 million.

  • Charles River Laboratories International's Deferred Taxes rose 30060.39% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.6 million, marking a year-over-year decrease of 1628.7%. This contributed to the annual value of -$67.4 million for FY2024, which is 3246.37% down from last year.
  • Per Charles River Laboratories International's latest filing, its Deferred Taxes stood at $25.9 million for Q3 2025, which was up 30060.39% from -$22.0 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Deferred Taxes registered a high of $25.9 million during Q3 2025, and its lowest value of -$41.4 million during Q4 2024.
  • Moreover, its 5-year median value for Deferred Taxes was -$11.6 million (2023), whereas its average is -$10.2 million.
  • Per our database at Business Quant, Charles River Laboratories International's Deferred Taxes skyrocketed by 47725.09% in 2021 and then plummeted by 182917.93% in 2025.
  • Over the past 5 years, Charles River Laboratories International's Deferred Taxes (Quarter) stood at -$10.2 million in 2021, then increased by 6.71% to -$9.6 million in 2022, then crashed by 136.92% to -$22.7 million in 2023, then tumbled by 82.94% to -$41.4 million in 2024, then skyrocketed by 162.52% to $25.9 million in 2025.
  • Its Deferred Taxes was $25.9 million in Q3 2025, compared to -$22.0 million in Q2 2025 and -$19.0 million in Q1 2025.